Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.

[1]  R. Garofalo,et al.  Concentrations of LTB4, LTC4, LTD4 and LTE4 in bronchiolitis due to respiratory syncytial virus , 1991 .

[2]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[3]  A. Ford-hutchinson.  Leukotriene B4 in inflammation. , 1990, Critical reviews in immunology.

[4]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[5]  J. Schröder,et al.  Differential Sensitivities of Purified Human Eosinophils and Neutrophils to Defined Chemotaxins , 1989, Scandinavian journal of immunology.

[6]  R. Kyle,et al.  IgA-induced eosinophil degranulation. , 1989, Journal of immunology.

[7]  D. Loegering,et al.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. , 1989, The American review of respiratory disease.

[8]  D. Agrawal,et al.  Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. , 1988, Journal of immunology.

[9]  B. Volovitz,et al.  The Release of Leukotrienes in the Respiratory Tract during Infection with Respiratory Syncytial Virus: Role in Obstructive Airway Disease , 1988, Pediatric Research.

[10]  N. Flavahan,et al.  The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.

[11]  N. Flavahan,et al.  Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. , 1988, The American review of respiratory disease.

[12]  A. Mukherjee,et al.  Relationship between leukotriene C4 and an uteroglobin-like protein in nasal and tracheobronchial mucosa of children. Implication in acute respiratory illnesses. , 1988, International archives of allergy and applied immunology.

[13]  P. Venge,et al.  Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis , 1987, Allergy.

[14]  P. Venge,et al.  Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.

[15]  E. Hey,et al.  Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. , 1982, British medical journal.

[16]  D. Wong,et al.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. , 1981, The New England journal of medicine.

[17]  M. Vadas,et al.  Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. , 1980, The New England journal of medicine.

[18]  P. Ogra,et al.  Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. , 1979, The Journal of pediatrics.

[19]  J. Clement,et al.  Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. , 1978, American journal of diseases of children.

[20]  I. Olsson,et al.  Radioimmunoassay of Human Eosinophil Cationic Protein , 1977, British journal of haematology.

[21]  T. Waldmann,et al.  Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. , 1970, Journal of immunology.

[22]  R. Chanock,et al.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.

[23]  E. H. Lennette,et al.  Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. , 1969, American journal of epidemiology.